Olutasidenib
CAS: 1887014-12-1
Indication: To treat relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation.
CAS: 1887014-12-1
Indication: To treat relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation.
Address: RM503, Wanhai Building B, Nanhai Avenue, Nanshan District,Shenzhen 518067 P.R. China.
Tel: (86) 755-82960263 (For All)
Web: www.haorui.com
Email: info@haorui.com
